Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
Clinical trial NCT02275338 · COMPLETED
Trial details
- NCT number
- NCT02275338
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-19
- Primary completion
- 2017-11-09
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.